238 related articles for article (PubMed ID: 24797657)
1. IQP-GC-101 reduces body weight and body fat mass: a randomized, double-blind, placebo-controlled study.
Chong PW; Beah ZM; Grube B; Riede L
Phytother Res; 2014 Oct; 28(10):1520-6. PubMed ID: 24797657
[TBL] [Abstract][Full Text] [Related]
2. Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects.
Uebelhack R; Bongartz U; Seibt S; Bothe G; Chong PW; De Costa P; Wszelaki N
J Obes; 2019; 2019():3412952. PubMed ID: 30863632
[TBL] [Abstract][Full Text] [Related]
3. A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study.
Grube B; Chong PW; Lau KZ; Orzechowski HD
Obesity (Silver Spring); 2013 Jan; 21(1):58-64. PubMed ID: 23505169
[TBL] [Abstract][Full Text] [Related]
4. Flaxseed Mucilage (IQP-LU-104) Reduces Body Weight in Overweight and Moderately Obese Individuals in a 12-week, Three-Arm, Double-Blind, Randomized, and Placebo-Controlled Clinical Study.
Bongartz U; Hochmann U; Grube B; Uebelhack R; Alt F; Erlenbeck C; Peng LV; Chong PW; De Costa P
Obes Facts; 2022; 15(3):395-404. PubMed ID: 35130547
[TBL] [Abstract][Full Text] [Related]
5. Weight reduction and maintenance with IQP-PV-101: a 12-week randomized controlled study with a 24-week open label period.
Grube B; Chong WF; Chong PW; Riede L
Obesity (Silver Spring); 2014 Mar; 22(3):645-51. PubMed ID: 24006357
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects.
Kudiganti V; Kodur RR; Kodur SR; Halemane M; Deep DK
Lipids Health Dis; 2016 Aug; 15(1):136. PubMed ID: 27558585
[TBL] [Abstract][Full Text] [Related]
7. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.
Heymsfield SB; Allison DB; Vasselli JR; Pietrobelli A; Greenfield D; Nunez C
JAMA; 1998 Nov; 280(18):1596-600. PubMed ID: 9820262
[TBL] [Abstract][Full Text] [Related]
8. Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study.
Grube B; Chong PW; Alt F; Uebelhack R
J Obes; 2015; 2015():953138. PubMed ID: 26435849
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a novel herbal formulation for weight loss demonstrated in a 16-week randomized, double-blind, placebo-controlled clinical trial with healthy overweight adults.
Dixit K; Kamath DV; Alluri KV; Davis BA
Diabetes Obes Metab; 2018 Nov; 20(11):2633-2641. PubMed ID: 29923305
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Sinetrol-XPur on Weight and Body Fat Reduction in Overweight or Obese Adults: A 12-Week, Randomized, Double-Blind, Parallel, Placebo-Controlled Trial.
Park SJ; Sharma A; Bae MH; Sung HC; Kim NK; Sung E; Lee HJ
J Med Food; 2020 Mar; 23(3):335-342. PubMed ID: 32130058
[TBL] [Abstract][Full Text] [Related]
11. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.
Rubino D; Abrahamsson N; Davies M; Hesse D; Greenway FL; Jensen C; Lingvay I; Mosenzon O; Rosenstock J; Rubio MA; Rudofsky G; Tadayon S; Wadden TA; Dicker D;
JAMA; 2021 Apr; 325(14):1414-1425. PubMed ID: 33755728
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of an herbal formulation for weight management.
Stern JS; Peerson J; Mishra AT; Mathukumalli VS; Konda PR
J Med Food; 2013 Jun; 16(6):529-37. PubMed ID: 23767862
[TBL] [Abstract][Full Text] [Related]
13. Effect of a herbal extract powder (YY-312) from Imperata cylindrica Beauvois, Citrus unshiu Markovich, and Evodia officinalis Dode on body fat mass in overweight adults: a 12-week, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
Cho YG; Jung JH; Kang JH; Kwon JS; Yu SP; Baik TG
BMC Complement Altern Med; 2017 Jul; 17(1):375. PubMed ID: 28754119
[TBL] [Abstract][Full Text] [Related]
14. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
[TBL] [Abstract][Full Text] [Related]
15. The Probiotic Strain
Déchelotte P; Breton J; Trotin-Picolo C; Grube B; Erlenbeck C; Bothe G; Fetissov SO; Lambert G
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205871
[No Abstract] [Full Text] [Related]
16. Efficacy and tolerability of a novel herbal formulation for weight management.
Stern JS; Peerson J; Mishra AT; Sadasiva Rao MV; Rajeswari KP
Obesity (Silver Spring); 2013 May; 21(5):921-7. PubMed ID: 23784895
[TBL] [Abstract][Full Text] [Related]
17. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation.
Ngondi JL; Etoundi BC; Nyangono CB; Mbofung CM; Oben JE
Lipids Health Dis; 2009 Mar; 8():7. PubMed ID: 19254366
[TBL] [Abstract][Full Text] [Related]
18. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
Belza A; Frandsen E; Kondrup J
Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study.
Shirai K; Fujita T; Tanaka M; Fujii Y; Shimomasuda M; Sakai S; Samukawa Y
Adv Ther; 2019 Jan; 36(1):86-100. PubMed ID: 30535651
[TBL] [Abstract][Full Text] [Related]
20. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Wadden TA; Bailey TS; Billings LK; Davies M; Frias JP; Koroleva A; Lingvay I; O'Neil PM; Rubino DM; Skovgaard D; Wallenstein SOR; Garvey WT;
JAMA; 2021 Apr; 325(14):1403-1413. PubMed ID: 33625476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
